Related Experiment Videos
[Treatment of hypertensive type 2 diabetes patients with microalbuminuria]
1Service d'Endocrinologie et de Diabétologie, Hôpital Bichat, Paris (75).
Primary Objective:
The first fundamental study devoted to the reduction of microalbuminuria with a antihypertensive diuretic (indapamide SR) in type 2 diabetes with hypertension, the Marre study (NESTOR) was designed to demonstrate that this antihypertension agent could be an interesting therapeutic alternative by comparing its efficacy on microalbuminuria with that of enalapril 10 mg during a treatment period of 52 weeks.
Results:
It was demonstrated that indapamide SR is the only diuretic providing a significant reduction (35%) in the microalbuminuria observed in hypertensive patients with type 2 diabetes. At the endpoint, comparison with the group of patients treated with enalapril, showed no significant difference in fractionated albumin clearance or in the percentage of patients with normoalbuminuria, microalbuminuria or gross proteinuria. Safety and tolerance were comparable for the two treatments.
Related Concept Videos
Diabetic Nephropathy
Diabetic Retinopathy
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Nephrotic Syndrome II : Assessment and Medical Management
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis